Development of a CD19-TAC therapy in preparation of human trials von Helsen, C.W, Hayes, D, Hammill, J, Aarts, C, Bader, A.G, Bramson, J

Volltext

BCMA-specific TAC receptor-engineered T cells for multiple myeloma von Bezverbnaya, K, Lau, V, Aarts, C, Denisova, G, Afsahi, A, Cummings, D, Helsen, C.W, Bramson, J

Volltext

T cells engineered with T-cell antigen coupler (TAC) receptors display robust efficacy against solid and liquid tumor xenografts in the absence of any toxicity von Helsen, C.W, Hammill, J, Mwawasi, K, Lau, V, Hayes, D, Afsahi, A, Bezverbnaya, K, Newhook, L, Aarts, C, Denisova, G, Bramson, J

Volltext

6 - BCMA-specific TAC receptor-engineered T cells for multiple myeloma von Bezverbnaya, K., Lau, V., Aarts, C., Denisova, G., Afsahi, A., Cummings, D., Helsen, C.W., Bramson, J.

Volltext

4 - T cells engineered with T-cell antigen coupler (TAC) receptors display robust efficacy against solid and liquid tumor xenografts in the absence of any toxicity von Helsen, C.W., Hammill, J., Mwawasi, K., Lau, V., Hayes, D., Afsahi, A., Bezverbnaya, K., Newhook, L., Aarts, C., Denisova, G., Bramson, J.

Volltext